NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report
Background: NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efcacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants are hetero...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
SpringerOpen
2021
|
Online Access: | http://psasir.upm.edu.my/id/eprint/94347/ https://ejnpn.springeropen.com/articles/10.1186/s41983-021-00397-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|